Some physicians still shy away from using thiazides first-line for hypertension due to concerns about inducing diabetes

Some physicians still shy away from using thiazides first-line for hypertension due to concerns about inducing diabetes.

It's true that thiazides increase the risk of hyperglycemia and new-onset diabetes.

But a new analysis of the large ALLHAT hypertension trial shows that this does NOT translate into a higher risk of CV events or death.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote